CYNTHIA MAI: Open Payments
NPI 1720606098 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,962 in 134 payments from 12 companies in 2025. Trend: 2023 $1,462 · 2024 $1,526 · 2025 $11,962
Speaker / faculty: $4,950Consulting: $3,710Food & beverage: $2,588Travel & lodging: $714
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 40 | $10,236 |
| Janssen Pharmaceuticals, Inc | 13 | $311 |
| Axsome Therapeutics, Inc. | 13 | $305 |
| Neurocrine BioSciences, Inc. | 19 | $300 |
| Teva Pharmaceuticals USA, Inc. | 15 | $268 |
| Otsuka America Pharmaceutical, Inc. | 11 | $167 |
| Lundbeck LLC | 11 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| ABBVIE INC. | 3 | $49 |
Products named: LYBALVI, ARISTADA, Auvelity, INGREZZA, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, UZEDY.
Industry payments across MI — which companies pay providers there.
